Eligibility for the Shorter Multidrug-Resistant Tuberculosis Regimen: Ambiguities in the World Health Organization Recommendations
Publisher
American Thoracic SocietyPubMed ID
27739887Language
enISSN
1535-4970ae974a485f413a2113503eed53cd6c53
10.1164/rccm.201605-1080LE
Scopus Count
Collections
Related articles
- Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe.
- Authors: Lange C, Duarte R, Fréchet-Jachym M, Guenther G, Guglielmetti L, Olaru ID, Oliveira O, Rumetshofer R, Veziris N, van Leth F, European MDR-TB database collaboration *.
- Issue date: 2016 Oct 15
- Towards all-oral and shorter treatment regimens for drug-resistant tuberculosis.
- Authors: Weyer K, Falzon D, Jaramillo E
- Issue date: 2018 Oct 1
- WHO recommendations on shorter treatment of multidrug-resistant tuberculosis.
- Authors: Sotgiu G, Tiberi S, D'Ambrosio L, Centis R, Zumla A, Migliori GB
- Issue date: 2016 Jun 18
- World Health Organization recommendations for multidrug-resistant tuberculosis: should different standards be applied?
- Authors: Cox V, Furin J
- Issue date: 2017 Dec 1
- New World Health Organization Treatment Recommendations for Multidrug-Resistant Tuberculosis: Are We Well Enough Prepared?
- Authors: Kranzer K, Kalsdorf B, Heyckendorf J, Andres S, Merker M, Hofmann-Thiel S, Bloemberg GV, Hoffmann H, Niemann S, Lange C, Maurer FP
- Issue date: 2019 Aug 15